SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001580642-24-000983
Filing Date
2024-02-14
Accepted
2024-02-14 12:04:28
Documents
1
Group Members
FINNY KURUVILLA, M.D. PH. D.ROBIN C. JOHN

Document Format Files

Seq Description Document Type Size
1 SC 13G/A sc13ga_collegiumpharm.htm SC 13G/A 54217
  Complete submission text file 0001580642-24-000983.txt   56093
Mailing Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072
Business Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072 781-713-3699
COLLEGIUM PHARMACEUTICAL, INC (Subject) CIK: 0001267565 (see all company filings)

IRS No.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88843 | Film No.: 24634785
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address ONE INTERNATIONAL PLACE SUITE 4210 BOSTON MA 02110
Business Address ONE INTERNATIONAL PLACE SUITE 4210 BOSTON MA 02110 877-771-3836
EVENTIDE ASSET MANAGEMENT, LLC (Filed by) CIK: 0001442891 (see all company filings)

IRS No.: 262508416 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A